DBCO-PEG4-SS-TCO is a cleavable ADC linker featuring DBCO and trans-cyclooctene moieties with a disulfide bond, enabling dual bioorthogonal conjugation and redox-triggered drug release in ADCs.
Structure of
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
DBCO-PEG4-SS-TCO, a versatile bifunctional linker, plays a pivotal role in bioorthogonal chemistry and bioconjugation applications. Here are four key applications of DBCO-PEG4-SS-TCO:
Targeted Drug Delivery: Acting as a bridge between therapeutic agents and targeting molecules like antibodies or ligands, DBCO-PEG4-SS-TCO facilitates precise drug delivery to specific sites in the body. This controlled release mechanism enhances therapeutic efficacy while minimizing off-target effects. Notably, the cleavable disulfide bond within DBCO-PEG4-SS-TCO ensures drug release in the reducing environment of target cells, optimizing treatment outcomes.
Protein Labeling: Exemplifying its utility, DBCO-PEG4-SS-TCO enables site-specific labeling of proteins by conjugating fluorescent dyes or detectable moieties. This strategic attachment empowers researchers to monitor protein localization, interactions, and dynamics in real-time within live cells. Such applications are invaluable for imaging studies and in-depth protein function analyses, shedding light on cellular processes with unprecedented clarity.
Bio-orthogonal Chemistry: Embracing bio-orthogonal reactions, DBCO-PEG4-SS-TCO engages in chemical transformations that harmonize seamlessly with native biochemical pathways. This unique trait renders it indispensable for in vivo investigations necessitating non-disruptive tracking and labeling of biomolecules. Scientists leverage DBCO-PEG4-SS-TCO for precise biomolecule modifications in intricate biological systems, paving the way for groundbreaking discoveries in molecular biology and beyond.
Surface Functionalization: Unveiling a realm of possibilities, DBCO-PEG4-SS-TCO serves as a catalyst for enhancing the biocompatibility and functionality of nanoparticles, polymers, and various biomaterials through surface modifications. These enhancements may include integrating targeting ligands, stealth coatings, or other functional groups that optimize interactions with biological systems. Such tailored modifications are instrumental in crafting cutting-edge materials for diagnostics, therapeutics, and tissue engineering, pushing the boundaries of scientific innovation.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-01010 | DBCO-PEG4-amine | 1840886-10-3 | |
BADC-01017 | DBCO-PEG5-acid | 1870899-46-9 | |
BADC-01536 | DBCO-Peg4-VC-PAB-MMAE | 2129164-91-4 | |
BADC-01073 | DBCO-PEG5-NHS ester | 2144395-59-3 | |
BADC-01077 | DBCO-PEG4-DBCO | 2182601-68-7 | |
BADC-00863 | DBCO-PEG4-Val-Cit-PAB-MMAF | 2244602-23-9 | |
BADC-01089 | DBCO-PEG3 acetic-EVCit-PAB | 2253947-17-8 | |
BADC-00868 | DBCO-(PEG2-VC-PAB-MMAE)2 | 2259318-55-1 | |
BADC-00762 | DBCO-PEG4-VC-PAB-DMEA-PNU159682 | 2259318-56-2 | |
BADC-00751 | DBCO-PEG4-MMAF | 2360411-65-8 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.